Phase I – Bioequivalence

295 trials 18 recruiting

Filter these 295 trials by condition, country, sponsor and more.

Open in Search →

Bioequivalence study of a proposed biosimilar insulin glargine U300 with Toujeo® Ended

2023-504509-36-00 Type 1 Diabetes Mellitus
Comparative Bioavailability of Diclofenac 2.32% Gel in Healthy Adult Subjects Ended

2023-507428-21-00 No medical condition.
A study to investigate the similarity of two different Tiotropium inhalers in healthy volunteers. Ended

2023-509025-41-00 No therapeutic indication in the current trial with hea
Bioequivalence of Lenvatinib 10 mg Capsules versus Lenvima® 10 mg Capsules in Healthy Participants Under Fed Conditions Ended

2024-512912-23-00 No medical condition
A study to investigate the similarity of two different Tiotropium inhalers in healthy volunteers. Ended

2024-515876-10-00 No therapeutic indication in the present bioequivalence
Comparative Bioavailability of Teriflunomide 14 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, … Ended

2024-516401-23-00 No medical condition.
Single dose oral bioequivalence study of Cladribine 10 mg Tablets and Mavenclad® 10 mg tablets (Cladribine) in healthy adult human subjects … Ended

2025-522252-74-00 No therapeutic indication in the current trial with hea